DICERNA PHARMACEUTICALS INC's ticker is DRNA and the CUSIP is 253031108. A total of 41 filers reported holding DICERNA PHARMACEUTICALS INC in Q2 2014. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $46,000 | -16.4% | 14,518 | -10.4% | 0.02% | 0.0% |
| Q1 2017 | $55,000 | -31.2% | 16,204 | -41.5% | 0.02% | -14.3% |
| Q4 2016 | $80,000 | -12.1% | 27,704 | -9.0% | 0.02% | +23.5% |
| Q2 2016 | $91,000 | -91.5% | 30,429 | -60.2% | 0.02% | -83.7% |
| Q2 2015 | $1,065,000 | +200.0% | 76,364 | +173.6% | 0.10% | +235.5% |
| Q3 2014 | $355,000 | +52.4% | 27,914 | +170.2% | 0.03% | +72.2% |
| Q2 2014 | $233,000 | – | 10,332 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RTW INVESTMENTS, LP | 2,005,238 | $16,463,000 | 5.12% |
| Abingworth LLP | 945,757 | $7,755,000 | 4.53% |
| RA Capital Management | 2,428,571 | $19,939,000 | 2.86% |
| Omega Fund Management, LLC | 223,457 | $1,835,000 | 1.03% |
| DAFNA Capital Management LLC | 123,500 | $1,014,000 | 1.01% |
| Iguana Healthcare Management, LLC | 100,000 | $821,000 | 0.32% |
| Cormorant Asset Management, LP | 245,000 | $2,011,000 | 0.32% |
| Eventide Asset Management | 315,300 | $2,589,000 | 0.15% |
| AWM Investment Company, Inc. | 80,000 | $657,000 | 0.13% |
| Palo Alto Investors LP | 267,890 | $2,199,000 | 0.11% |